Wednesday, June 10, 2026

biotech · Pulmonary Disease, Chronic Obstructive · Symptomatic Neurogenic Orthostatic Hypertension · TBPH

Theravance Biopharma Ireland

News and analysis for Theravance Biopharma Ireland on NovaPharmaNews — regulatory, clinical, and market coverage.

901 Gateway Blvd., South San Francisco, CA 94080, US HQ
2014 Founded
177 Employees
Public company Type
TBPH · NYSE Ticker
Company details
Status
Public
HQ
901 Gateway Blvd., South San Francisco, CA 94080, US
Founded
2014
Employees
177
Programs
57
Drugs
18
Patents
635
Intelligence · Coverage

News & analysis

NovaPharmaNews articles mentioning Theravance Biopharma Ireland — regulatory, clinical, and market coverage.

News and analysis for Theravance Biopharma Ireland on NovaPharmaNews — regulatory, clinical, and market coverage.

No coverage yet

We have not published news or analysis mentioning Theravance Biopharma Ireland yet.

Back to company overview →